# GRAP2

## Overview
GRAP2, or GRB2 related adaptor protein 2, is a gene that encodes a leukocyte-specific adaptor protein involved in intracellular signaling pathways, particularly within the immune system. The protein, also referred to as Gads, is characterized by its SH3-SH2-SH3 domain configuration, which facilitates its role in signal transduction by mediating protein-protein interactions. GRAP2 is predominantly expressed in lymphoid tissues and plays a crucial role in T-cell receptor (TCR) signaling by forming complexes with proteins such as LAT and SLP-76, essential for the activation of downstream signaling pathways. These interactions are vital for the regulation of immune responses, including T cell activation and differentiation. Additionally, GRAP2 is involved in both positive and negative regulatory pathways, highlighting its importance in maintaining immune cell signaling homeostasis (Yablonski2019Bridging; Qiu1998Molecular; Ma2001Leukocytespecific).

## Structure
The GRAP2 protein, also known as Grb-2 related adaptor protein 2, is characterized by its SH3-SH2-SH3 domain configuration, similar to other adaptor proteins like Grb-2 and Grap. The protein consists of 330 amino acids and includes a unique 120-amino acid glutamine-rich domain between the SH2 and C-terminal SH3 domains, which does not show homology to any known proteins (Qiu1998Molecular). This domain is also described as glutamine- and proline-rich (Ma2001Leukocytespecific).

The SH3 domains of GRAP2 are responsible for binding to proline-rich sequences, while the SH2 domain binds to phosphotyrosine residues, facilitating specific protein-protein interactions. The C-terminal SH3 domain is particularly important for binding to Gab-1, a multisubstrate docking protein, and hematopoietic progenitor kinase 1 (HPK1), which is crucial for activating the JNK signaling pathway in T lymphocytes (Qiu1998Molecular; Ma2001Leukocytespecific).

GRAP2 is expressed specifically in leukocytes and lymphoid tissues, indicating its role in immune cell signaling pathways (Qiu1998Molecular; Ma2001Leukocytespecific). The protein may undergo post-translational modifications such as phosphorylation, which are common in signaling proteins, although specific modifications are not detailed in the provided context. Splice variant isoforms of GRAP2 could contribute to structural and functional diversity, but specific variants are not mentioned in the context.

## Function
GRAP2, also known as GRB2 related adaptor protein 2, is a leukocyte-specific adaptor protein involved in intracellular signaling pathways, particularly in T lymphocytes. It contains SH2 and SH3 domains, which facilitate its role in signal transduction by recruiting cytosolic molecules to activated receptor tyrosine kinases (Qiu1998Molecular). GRAP2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate the c-Jun N-terminal kinase (JNK) signaling pathway, which is crucial for T cell activation and immune response regulation (Ma2001Leukocytespecific).

The protein is specifically expressed in lymphoid tissues and T cells, where it forms signaling complexes with proteins like SLP-76 and LAT, influencing the activation of nuclear factors such as NF-AT and the transcription of interleukin-2 (IL-2) (Ma2001Leukocytespecific). GRAP2's interaction with HPK1 enhances HPK1's kinase activity, leading to increased JNK activity and transcriptional activation of c-Jun, which are important for T cell growth and differentiation (Ma2001Leukocytespecific).

In B cells, GRAP2 negatively regulates the B cell receptor (BCR) signaling cascade by inhibiting global tyrosine phosphorylation, affecting the phosphorylation of key BCR substrates (GarrettSinha2005Spi1). This regulatory function highlights GRAP2's role in modulating immune cell signaling and maintaining cellular homeostasis.

## Clinical Significance
Mutations or alterations in the expression of the GRAP2 gene, which encodes the Gads protein, have been implicated in various immune-related conditions. Gads is crucial for T cell receptor (TCR) signaling, and its deficiency can lead to impaired TCR responsiveness. This impairment is characterized by a non-naïve, CD44 high phenotype in peripheral T cells, similar to that observed in mice lacking the Tec-family kinase Itk. Such alterations may result in a skewed TCR repertoire, allowing self-reactive T cell clones to mature, which are typically eliminated by negative selection. This can lead to the development of specialized T cell sub-populations with innate-like phenotypes (Yablonski2019Bridging).

In the context of breast cancer, altered methylation patterns of the GRAP2 gene in circulating free DNA (cfDNA) have been identified as potential molecular markers for diagnosis. The methylation levels of GRAP2, along with other genes, show significant differences between cancerous and adjacent tissues, suggesting its utility in non-invasive diagnostics (Hu2024Value).

While specific diseases directly caused by GRAP2 mutations are not explicitly mentioned, disruptions in its function could affect immune responses, particularly in allergic reactions and immune deficiencies (Yablonski2019Bridging; Ruminski2023Mapping).

## Interactions
GRAP2, also known as GADS, is a member of the GRB2 family of adaptor proteins and plays a crucial role in T-cell receptor (TCR) signaling by facilitating protein-protein interactions. GRAP2 primarily interacts with the proteins LAT and SLP-76, forming a complex known as the LAT signalosome, which is essential for TCR-induced signaling pathways. This interaction is mediated through the SH2 domain of GRAP2, which binds to phosphorylated tyrosine residues on LAT, enabling the recruitment of SLP-76 into signaling microclusters (Yablonski2019Bridging; Ruminski2023Mapping).

GRAP2 also interacts with other proteins such as PLC-γ1, MAP4K1, CD6, and VAV1/3, which are part of the SLP76 interactome. These interactions are crucial for the docking of SLP-76 to LAT upon TCR stimulation, highlighting the importance of GRAP2 in maintaining the integrity of the signaling complex (Ruminski2023Mapping). Additionally, GRAP2 can bind to proteins containing an RxxK motif, such as Gab1, AMSH, and USP8, and its C-terminal SH3 domain can bind to RxxK motifs in HPK1 and Gab3 (Yablonski2019Bridging).

GRAP2's interactions are not limited to positive signaling roles; it is also involved in negative regulatory pathways. For instance, HPK1-mediated phosphorylation and caspase-mediated cleavage of GRAP2 can disassemble signaling complexes, thus regulating TCR signaling (Yablonski2019Bridging). These interactions underscore GRAP2's role in both promoting and regulating immune cell signaling.


## References


[1. (Ma2001Leukocytespecific) Wenbin Ma, Chunzhi Xia, Pin Ling, Mengsheng Qiu, Ying Luo, Tse-Hua Tan, and Mingyao Liu. Leukocyte-specific adaptor protein grap2 interacts with hematopoietic progenitor kinase 1 (hpk1) to activate jnk signaling pathway in t lymphocytes. Oncogene, 20(14):1703–1714, March 2001. URL: http://dx.doi.org/10.1038/sj.onc.1204224, doi:10.1038/sj.onc.1204224. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1204224)

[2. (Yablonski2019Bridging) Deborah Yablonski. Bridging the gap: modulatory roles of the grb2-family adaptor, gads, in cellular and allergic immune responses. Frontiers in Immunology, July 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.01704, doi:10.3389/fimmu.2019.01704. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.01704)

[3. (Qiu1998Molecular) Mengsheng Qiu, Shaobing Hua, Manisha Agrawal, Guanyu Li, Jun Cai, Eva Chan, Helen Zhou, Ying Luo, and Mingyao Liu. Molecular cloning and expression of humangrap-2, a novel leukocyte-specific sh2- and sh3-containing adaptor-like protein that binds togab-1. Biochemical and Biophysical Research Communications, 253(2):443–447, December 1998. URL: http://dx.doi.org/10.1006/bbrc.1998.9795, doi:10.1006/bbrc.1998.9795. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/bbrc.1998.9795)

[4. (GarrettSinha2005Spi1) Lee Ann Garrett-Sinha, Ping Hou, Duncheng Wang, Brian Grabiner, Elizabeth Araujo, Sridhar Rao, Theodore J. Yun, Edward A. Clark, M. Celeste Simon, and Marcus R. Clark. Spi-1 and spi-b control the expression of the grap2 gene in b cells. Gene, 353(1):134–146, June 2005. URL: http://dx.doi.org/10.1016/j.gene.2005.04.009, doi:10.1016/j.gene.2005.04.009. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2005.04.009)

[5. (Hu2024Value) Qin Hu, Yu Mao, Haomiao Lan, Yi Wei, Yuehua Chen, Qiang Ye, and Hongying Che. Value of altered methylation patterns of genes ranbp3, lcp2 and grap2 in cfdna in breast cancer diagnosis. Journal of Medical Biochemistry, 43(4):387–396, 2024. URL: http://dx.doi.org/10.5937/jomb0-47507, doi:10.5937/jomb0-47507. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.5937/jomb0-47507)

[6. (Ruminski2023Mapping) Kilian Ruminski, Javier Celis-Gutierrez, Nicolas Jarmuzynski, Emilie Maturin, Stephane Audebert, Marie Malissen, Luc Camoin, Guillaume Voisinne, Bernard Malissen, and Romain Roncagalli. Mapping the slp76 interactome in t cells lacking each of the grb2-family adaptors reveals molecular plasticity of the tcr signaling pathway. Frontiers in Immunology, March 2023. URL: http://dx.doi.org/10.3389/fimmu.2023.1139123, doi:10.3389/fimmu.2023.1139123. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2023.1139123)